Document is current
Any future updates will be listed below
-
Authors
Mohaupt, Pablo
Kindermans, Jana
Vialaret, Jérôme
Anderl-Straub, Sarah
Werner, Leonie
Lehmann, Sylvain
Hirtz, Christophe
Otto, Markus
Oeckl, Patrick
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
- License Information
-
More Information
Article History
Received: 15 April 2024
Accepted: 11 December 2024
First Online: 30 December 2024
Declarations
:
: All individuals or their legal proxies provided written informed consent for inclusion into this study and it was approved by the ethics committee of Ulm University (approval number 39/11).
: Not applicable.
: PO received research support from the Alzheimer Forschung Initiative e.V. (20059CB), ALS Association/ALS Finding A Cure (24-SGP-691, 23-PPG-674-2)), Charcot Foundation (D.7090), DZNE Innovation-to-Application (I2A_call7_Oeckl, I2A_call9_Oeckl) and consulting fees from LifeArc and Fundamental Pharma.
